1 / 38

White Blood Cell Disorders

White Blood Cell Disorders. Jonathan Ben-Ezra, M.D. Professor of Pathology MCV Campus of VCU. White Blood Cells. Infection fighting cells of blood Excess causes tissue infiltration/leukostasis 4.4- 5.9 x 10 6 /L (M) 3.8 -5.2 x 10 6 /L (F) Several Types of Cells Granulocytes Lymphocytes

Jims
Télécharger la présentation

White Blood Cell Disorders

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. White Blood Cell Disorders Jonathan Ben-Ezra, M.D. Professor of Pathology MCV Campus of VCU

  2. White Blood Cells • Infection fighting cells of blood • Excess causes tissue infiltration/leukostasis • 4.4- 5.9 x 106/L (M) • 3.8 -5.2 x 106/L (F) • Several Types of Cells • Granulocytes • Lymphocytes • Monocytes

  3. Granulocytes • Produced in the Bone Marrow • Neutrophils • Life span of 8 hours • Bacteriocidal • Eosinophils • Basophils • Approximately 2/3 of WBCs in Blood

  4. Granulocytes • Increased in Bacterial Infection • May see early forms (left shift) • Increased in Myeloid Leukemia

  5. Lymphocytes • B cells • Antibody production • T cells • Fight viral infection • Morphologically can’t distinguish between the two • Approximately 30% of WBCs in PB • Increased in viral infections and lymphoid leukemia

  6. Monocytes • Become tissue macrophages • Involved in phagocytosis • Approximately 15% of WBCs in PB

  7. WBC Maturation

  8. Leukemia • Neoplastic Proliferations of WBCs in Blood and Bone Marrow • Anemia, infection, bleeding • Acute Leukemias • Blast (precursor) cells • Rapidly fatal if not treated • Chronic Leukemias • More mature cells • Longer life expectancy

  9. Leukemia

  10. Acute Lymphoblastic Leukemia • Proliferation of lymphoblasts • anemia, thrombocytopenia, increased WBC • lymphadenopathy/splenomegaly • B- or T-cell • flow cytometry • TdT+ • Most common leukemia of childhood

  11. Acute Lymphoblastic Leukemia

  12. Acute Myelogenous Leukemia • Proliferation of myeloblasts • anemia, thrombocytopenia, increased WBC • Myeloid, monocytic, RBC, or megakaryocytic • flow cytometry • myeloperoxidase +, TdT- • Auer rod • Over age of 20

  13. Acute Myelogenous Leukemia

  14. Chronic Myelogenous Leukemia • 1 of myeloproliferative diseases (PV, ET) • Proliferation of more mature granulocytes • normal to increased platelet count • anemia • Splenomegaly • t(9;22) (bcr-abl) (Philadelphia chromosome)

  15. Chronic Myelogenous Leukemia • Long chronic phase • Blast crisis • Hydroxyurea, interferons • Bone marrow transplantation

  16. Chronic Myelogenous Leukemia

  17. Myelofibrosis • Marrow becomes fibrotic • extramedullary hematopoiesis • dry tap • Teardrop RBC • Myeloproliferative, toxin, infection

  18. Chronic Lymphocytic Leukemia • Proliferation of small mature B-lymphocytes • flow cytometry (monoclonal Kappa or lambda) • Lymphadenopathy • relationship to small lymphocytic lymphoma • May have Ab production and AIHA • 50% 5-year survival

  19. Chronic Lymphocytic Leukemia

  20. Multiple Myeloma • Neoplasm of plasma cells • monoclonal protein in serum (SPEP) • Proteinuria (Bence-Jones) (UPEP) • Lytic lesions in bones • fractures • Anemia, increased globulin • Rouleaux formation • Renal failure/ amyloidosis

  21. Multiple Myeloma

  22. Infectious Mononucleosis • Acute infection with EBV • Adolescent/Young Adult • Fever, sore throat, splenomegaly, fatigue • Heterophile antibodies • Usually self limited

  23. Lymphomas • Nodal based malignant proliferations of lymphoid cells • Hodgkin’s disease • Non-Hodgkin’s lymphoma • follicular vs. diffuse • small vs. large cell • Staging

  24. Diffuse vs. Follicular Lymphoma

  25. Low grade NHL • Small lymphocytic lymphoma • nodal counterpart for CLL • Follicular lymphomas • B-cell • t(14;18) • failure of apoptosis

  26. Small Lymphocytic Lymphoma

  27. Follicular Lymphoma

  28. Follicular Lymphoma

  29. High Grade NHL • May be nodal or extranodal • May be T- or B-cell • Adults or pediatric • Large cell lymphoma • Burkitt’s lymphoma • t(8;14) • related to EBV • Lymphoblastic lymphoma

  30. Large Cell Lymphoma

  31. Burkitt’s Lymphoma

  32. Burkitt’s Lymphoma

  33. Extranodal Marginal Zone B-cell Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) • Proliferation of mucosal associated lymphoid tissue • Small lymphoid cells, with/out abundant cytoplasm • May transform to large cell lymphoma • Median survival of 8 years

  34. Extranodal Marginal Zone B-cell Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT)

  35. Hodgkin Lymphoma • Bimodal age distribution • Related to EBV • Reed Sternberg cell • other background inflammatory cells • Radiation, chemotherapy, or BMT

  36. Hodgkin Lymphoma • Nodular Lymphocyte Predominant • Nodular Sclerosis • Mixed Cellularity • Lymphocyte Depleted

  37. Hodgkin Lymphoma

More Related